Results 1 to 10 of about 861,404 (347)
PurposeSepsis with thrombocytopenia is highly prevalent in critically ill intensive care unit (ICU) patients and is associated with adverse outcomes. Platelet transfusion is the primary treatment of choice. However, evidence for the beneficial effects of
Shuangjun He +4 more
doaj +2 more sources
Platelet Transfusion: And Update on Challenges and Outcomes
Pilar Solves Alcaina Blood Bank, Hematology Service, Hospital Universitari I Politècnic La Fe, Valencia, CIBERONC, Instituto Carlos III, Madrid, SpainCorrespondence: Pilar Solves AlcainaBlood Bank, Hematology Service, Hospital Universitari I Polit&
Solves Alcaina P
doaj +2 more sources
Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia.
BACKGROUND Transfusion guidelines regarding platelet-count thresholds before the placement of a central venous catheter (CVC) offer conflicting recommendations because of a lack of good-quality evidence.
Floor L F van Baarle +19 more
semanticscholar +3 more sources
ABO-identical versus incompatible platelet transfusion in patients with intracranial hemorrhage. [PDF]
BackgroundPatients with spontaneous and traumatic intracranial hemorrhage (ICH) are frequently transfused platelets to treat thrombocytopenia, platelet function defects, and reverse antiplatelet drugs.
Lauren K Dunn +7 more
doaj +2 more sources
Purpose of review Platelet transfusions, used as prophylaxis or treatment for bleeding, are potentially life-saving. In many countries, demand for platelet transfusion is rising. Platelets are a limited and costly resource, and it is vital that they are used appropriately.
Agarwal A, Khan AI, Anwer F.
europepmc +4 more sources
Mechanism and transfusion strategy of immunogenic platelet transfusion refractoriness
Platelet transfusion is an irreplaceable method to treat patients with platelet reduction in Hematology Department and Oncology Department. However, immunogenic platelet transfusion refractoriness is a huge challenge to patients who require repeatedly ...
Juan SAI, Li TIAN
doaj +1 more source
Transfusion effect of 0.5-dose of apheresis platelet in pediatric patients
Objective To investigate the transfusion effect of 0.5-dose of apheresis platelet in pediatric patients. Methods A total of 195 children who underwent 0.5-dose platelet transfusion from August 2021 to June 2022 were enrolled, and the platelet count ...
Lijuan QIU +3 more
doaj +1 more source
Two-year outcomes following a randomised platelet transfusion trial in preterm infants
Objective Assess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia in Special Subgroup) study, which reported ...
C. Moore +21 more
semanticscholar +1 more source
Conventional platelet transfusion may not be adequate to deal with platelet transfusion refractoriness (PTR), and therefore human leukocyte antigen (HLA) or human platelet antigen (HPA) matched and platelet crossmatch compatible units are recommended ...
Gayathiri K Chellaiya +5 more
doaj +1 more source
Supplemental Digital Content is available in the text. OBJECTIVES: Critically ill children frequently receive plasma and platelet transfusions. We sought to determine evidence-based recommendations, and when evidence was insufficient, we developed expert-
Marianne E. Nellis +28 more
semanticscholar +1 more source

